462 related articles for article (PubMed ID: 12444994)
61. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.
Siewert JR; Feith M; Stein HJ
J Surg Oncol; 2005 Jun; 90(3):139-46; discussion 146. PubMed ID: 15895452
[TBL] [Abstract][Full Text] [Related]
62. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
63. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
[TBL] [Abstract][Full Text] [Related]
64. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
65. Limited resection for early adenocarcinoma in Barrett's esophagus.
Stein HJ; Feith M; Mueller J; Werner M; Siewert JR
Ann Surg; 2000 Dec; 232(6):733-42. PubMed ID: 11088068
[TBL] [Abstract][Full Text] [Related]
66. Challenges in the treatment of gastroesophageal junction cancer.
Liakakos T
World J Surg; 2011 Jun; 35(6):1409-10; author reply 1411. PubMed ID: 21301836
[No Abstract] [Full Text] [Related]
67. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
[TBL] [Abstract][Full Text] [Related]
68. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
[No Abstract] [Full Text] [Related]
69. Technical aspects and results of the transhiatal resection in adenocarcinomas of the gastroesophageal junction.
Ulrich B; Zahedi A
Dis Esophagus; 2001; 14(2):115-9. PubMed ID: 11553220
[TBL] [Abstract][Full Text] [Related]
70. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction.
Liu JF; Jiang T; Shi ZH; Liu XB
ANZ J Surg; 2018 Mar; 88(3):218-222. PubMed ID: 27444989
[TBL] [Abstract][Full Text] [Related]
71. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.
Kawaguchi T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
Anticancer Res; 2013 Aug; 33(8):3461-5. PubMed ID: 23898120
[TBL] [Abstract][Full Text] [Related]
72. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
[TBL] [Abstract][Full Text] [Related]
73. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
74. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
Hagen JA; Peters JH; DeMeester TR
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
[TBL] [Abstract][Full Text] [Related]
75. Current surgical treatment standards for esophageal and esophagogastric junction cancer.
Jung MK; Schmidt T; Chon SH; Chevallay M; Berlth F; Akiyama J; Gutschow CA; Mönig SP
Ann N Y Acad Sci; 2020 Dec; 1482(1):77-84. PubMed ID: 32798235
[TBL] [Abstract][Full Text] [Related]
76. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
77. [Adenocarcinomas of the distal esophagus and cardia: surgical management].
Triboulet JP; Fabre S; Castel B; Toursel H
Cancer Radiother; 2001 Nov; 5 Suppl 1():90s-97s. PubMed ID: 11797291
[TBL] [Abstract][Full Text] [Related]
78. [Survival rate of proximal and total gastrectomy in treatment of esophagogastric junction adenocarcinoma (Siewert II( Types)].
Nai C; Liu Z; Lian X; Liu S; Guo M; Xiao S; Liu J; Yang X; Zhang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):195-9. PubMed ID: 26831885
[TBL] [Abstract][Full Text] [Related]
79. Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction.
Saha S; Dehn TC
Dis Esophagus; 2001; 14(1):32-6. PubMed ID: 11422303
[TBL] [Abstract][Full Text] [Related]
80. Surgical Protocol for Esophageal Adenocarcinoma.
Law S
Methods Mol Biol; 2018; 1756():35-50. PubMed ID: 29600358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]